PMV Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-1.26 | -274.25 | -99.54% | -4.26 | -70.49% |
| P/S |
|
0 | 56.99 | -100% |
|
|
| P/BV |
|
0.4423 | 256.7 | -99.83% |
|
|
| P/FCF |
|
-1.42 | -196.64 | -99.28% |
|
|
| Ev/Ebitda |
|
-0.5185 | 12.51 | -104.14% |
|
|
| Ev/S |
|
0 | 468.02 | -100% |
|
|
| Ev/FCF |
|
-0.7355 | -237.28 | -99.69% |
|
|
| E/P |
|
-0.796 | 0.0224 | -3659.24% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | -341.3 | -100% | 0 | 0% |
| ROE |
|
-29.23 | 103.63 | -128.2% |
|
|
| ROA |
|
-26.48 | -2.84 | 832.99% |
|
|
| ROIC |
|
-19.92 | 1.17 | -1796.85% |
|
|
| ROS |
|
0 | -298.77 | -100% |
|
|
| ROCE |
|
-42.49 | 3.3 | -1387.68% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0162 | 0.9675 | -101.67% | -0.1169 | -86.18% |
| Nеt Debt/Ebitda |
|
0.5387 | 1.05 | -48.65% |
|
|
| Debt/Ratio |
|
0.0062 | 0.179 | -96.53% |
|
|
| Debt/Equity |
|
0.0864 | 1.58 | -94.55% |
|
|
| Debt/Net Income |
|
-0.0203 | -1.51 | -98.66% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5335 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.8 | -100% | ||
| DSI |
|
0 | 0.2238 | -100% |
|
|
| Average dividend growth |
|
0 | 0.6549 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.5095 | -100% |
|
|
| Average percentage for payments |
|
0 | 59.63 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5335 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | -90.69 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
111.07 | -111.17 | -199.91% | ||
| Growth impulse Net Income in 5 years |
|
70.67 | -103.34 | -168.39% | ||
| Growth impulse FCF in 5 years |
|
57.86 | -114.74 | -150.43% | ||
| Growth impulse EPS in 5 years |
|
-52.57 | -98.04 | -46.38% |
IP Score
3.71/10
